• Work with us
  • External Contractors
Fondazione Toscana Life Sciences
  • IT
  • EN
Toscana Life Sciences
  • THE FOUNDATION
    • Organization
    • History
    • Membership
    • The Legislative Decree No. 231/2001
    • Results
  • Activity
  • Cluster
  • ITS VITA
  • BIOINCUBATOR
    • Join the Bioincubator
    • Incubated companies
    • Research groups
    • Affiliated companies
  • Services
    • Business development services
    • Research services
    • Incubation services
    • Protection of intellectual property
  • Projects
    • Monoclonal Antibody Discovery (MAD) LAB
    • ERC Advanced Grant VACCIBIOME
    • TUMOUR IMMUNOLOGY UNIT
    • Mass Spectrometry Unit
    • BOTANICALS LAB
    • Data Science for Health (DaScH) Lab
    • Regions4PerMed
    • IDF SHARID
    • BORNTOGEtTHERe
    • SINO-EU‐PERMED
    • Orphan diseases
  • Disseminating
    • TLS Open Doors
    • Scientists for a day
    • Science + Economy = Business
    • Researcher’s Night
    • European Biotech Week
  • Stories
Enter any keyword and press enter

Rino Rappuoli

  • Projects
    • Monoclonal Antibody Discovery (MAD) LAB
    • ERC Advanced Grant VACCIBIOME
    • TUMOUR IMMUNOLOGY UNIT
    • Mass Spectrometry Unit
    • BOTANICALS LAB
    • Data Science for Health (DaScH) Lab
    • Regions4PerMed
    • MammoScreen
    • IDF SHARID
    • BORNTOGEtTHERe
    • SINO-EU‐PERMED
< Back to project

Rino Rappuoli

Rino Rappuoli is Chief Scientist and Head External R&D at GSK Vaccines, based in Siena, Italy and Professor of Vaccines Research, Imperial College, London. Prior positions were: head of Vaccine R&D at Novartis, CSO of Chiron Corporation, and head for R&D at Sclavo. He earned his PhD in Biological Sciences at the University of Siena, Italy, and was visiting scientist at Rockefeller University and Harvard Medical School.
He is elected member of US National Academy of Sciences (NAS), the European Molecular Biology Organization (EMBO), and the Royal Society of London. Awards received include: the Paul Ehrlich and Ludwig Darmstaedter Prize, the Gold Medal by the Italian President, the Albert B Sabin Gold Medal, the Canada Gairdner International Award, and the European Inventor Award for Lifetime Achievement. He was nominated third most influential person worldwide in the field of vaccines (Terrapin). He has published more than 690 works in peer-reviewed journals.
He introduced novel scientific concepts: genetic detoxification; cellular microbiology; reverse vaccinology; pangenome. Developed licensed vaccines: acellular pertussis containing a non-toxic mutant of pertussis toxin; the first conjugate vaccine against meningococcus C; MF59, the first vaccine adjuvant after aluminium salts; meningococcus B; CRM197 that is used as carrier in many conjugate vaccines.
Dr. Rappuoli is among the world scientific leaders dedicated to the sustainability of global health.




Contacts:

Cristina Tinti
c.tinti@toscanalifesciences.org



Principal Investigator: Rino Rappuoli

Research Group:
Claudia Sala
c.sala@toscanalifesciences.org

Emanuele Andreano
e.andreano@toscanalifesciences.org

Marco Troisi
m.troisi@toscanalifesciences.org

Dario Cardamone d.cardamone@toscanalifesciences.org

Anna Kabanova a.kabanova@toscanalifesciences.org

Concetta De Santi c.desanti@toscanalifesciences.org

Ida Paciello i.paciello@toscanalifesciences.org

Fabiola Vacca f.vacca@toscanalifesciences.org

Noemi Manganaro n.manganaro@toscanalifesciences.org

Elisa Pantano e.pantano@toscanalifesciences.org


Scientific Advisory Board (SAB):
Oretta Finco
Mariagrazia Pizza
Isabel Delany
Aldo Tagliabue

Fondazione Toscana Life Sciences
Via Fiorentina, 1
53100 Siena – ITALIA

  • tel +39 0577 231211
  • fax +39 0577 43444
  • info@toscanalifesciences.org

Twitter Feeds

🗣Se hai esperienza nel Project Management e sei alla ricerca di una nuova sfida professionale unisciti al Project M…

@FondazioneTLS About a Day Ago

🗣Studia, cresci, vola a Siena. Torna la terza edizione di STAYHub, un programma ideato dal polo SAIHUB con Fondazio…

@FondazioneTLS 4 Days Ago

🗣Le nostre imprese ⚙️fanno un'impresa eccezionale. Guardando alle aziende e ai gruppi di ricerca del bioincubatore…

@FondazioneTLS 6 Days Ago

Contatti

    Concedo il consenso al trattamento dei dati personali secondo la nostra Privacy Policy per poter essere contattato da Fondazione Toscana Life Sciences.

©2015-2021 - Fondazione Toscana Life Sciences - P.I. 01194710529 - Codice SDI: SUBM70N - Privacy - Cookie Policy